Evidence map›Paper›PMID 31071154›Full record

ArticlePloS one2019

qPCR assays to quantitate tRNApyl and pylRS expression in engineered cell lines.

Andrew Garcia, Gargi Roy, Christine Kiefer, Susan Wilson, Marcello Marelli

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Inducible Genetic Code Expansion in Eukaryotes.Chembiochem : a European journal of chemical biology · 2020
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Andrew GarciaDepartment of Antibody Discovery and Protein Engineering, AstraZeneca, Gaithersburg, MD, United States of America.
Gargi RoyDepartment of Antibody Discovery and Protein Engineering, AstraZeneca, Gaithersburg, MD, United States of America.
Christine KieferDepartment of Antibody Discovery and Protein Engineering, AstraZeneca, Gaithersburg, MD, United States of America.ORCID 0000-0003-0823-9502
Susan WilsonDepartment of Antibody Discovery and Protein Engineering, AstraZeneca, Gaithersburg, MD, United States of America.
Marcello MarelliDepartment of Antibody Discovery and Protein Engineering, AstraZeneca, Gaithersburg, MD, United States of America.ORCID 0000-0001-7095-8263
AstraZeneca (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-natural amino acids (nnAA) contain unique functional moieties that greatly expand the available tool set for protein engineering. But incorporation of nnAAs requires the function of an orthogonal aminoacyl tRNA synthetase/tRNA pair. Stable cell lines expressing these components have been shown capable of producing gram per liter levels of antibodies with nnAAs. However, little has been reported on the genetic makeup of these cells. To gain a better understanding of the minimal requirements for efficient nnAA incorporation we developed qPCR methods for the quantitation of the key components. Here we describe the development of qPCR assays for the quantification of tRNApyl and pylRS. qPCR was chosen because it provides a large dynamic range, has high specificity for its target, and is a non-radioactive method used routinely for cell line characterization. Designing assays for tRNAs present challenges due to their short length (~72 nucleotides) and high secondary structure. These tRNA assays have a ≥ 5 log dynamic range with the tRNApyl assays being able to discern the mature and unprocessed forms of the tRNApyl. Cell line analysis showed tRNApyl was expressed at higher levels than the CHO-K1 endogenous Met and Phe tRNAs and that >88% of tRNApyl was the mature form.

Indexed as

Amino Acyl-tRNA SynthetasesBacterial ProteinsMethanosarcinaAnimalsCHO CellsCricetulusGenetic EngineeringLysineReal-Time Polymerase Chain ReactionRNA, TransferAmino Acyl-tRNA SynthetasesBacterial ProteinsLysinepyrrolysineRNA, Transfer

Identifiers

PMID31071154
PMCPMC6508675
OpenAlexW2944003681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.